Hrt Financial LP Galera Therapeutics, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.14 - $0.27 $126 - $244	907 Added 6.1%	15,782 $2,000
Q4 2023 Feb 09, 2024	SELL	$0.09 - $0.27 $15,992 - $47,978	-177,699 Reduced 92.28%	14,875 $2,000
Q3 2023 Nov 13, 2023	BUY	$0.17 - $3.0 $32,737 - $577,722	192,574 New	192,574 $33,000
Q1 2022 May 16, 2022	SELL	$2.01 - $4.19 $42,539 - $88,677	-21,164 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.27 - $8.28 $8,206 - $53,505	6,462 Added 43.95%	21,164 $97,000
Q3 2021 Nov 15, 2021	SELL	$7.04 - $10.49 $68,231 - $101,669	-9,692 Reduced 39.73%	14,702 $119,000
Q2 2021 Aug 16, 2021	BUY	$6.08 - $10.44 $148,315 - $254,673	24,394 New	24,394 $239,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.34M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.